Baxter International Inc (NYSE:BAX) Shares Sold by Voya Investment Management LLC

Share on StockTwits

Voya Investment Management LLC lessened its holdings in Baxter International Inc (NYSE:BAX) by 4.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,997,981 shares of the medical instruments supplier’s stock after selling 132,013 shares during the period. Voya Investment Management LLC owned 0.59% of Baxter International worth $262,234,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Webster Bank N. A. lifted its stake in shares of Baxter International by 40.1% during the second quarter. Webster Bank N. A. now owns 960 shares of the medical instruments supplier’s stock valued at $78,000 after buying an additional 275 shares during the period. Marathon Asset Management LLP lifted its stake in shares of Baxter International by 2.0% during the second quarter. Marathon Asset Management LLP now owns 634,464 shares of the medical instruments supplier’s stock valued at $52,096,000 after buying an additional 12,399 shares during the period. First Hawaiian Bank lifted its stake in shares of Baxter International by 3.9% during the second quarter. First Hawaiian Bank now owns 16,962 shares of the medical instruments supplier’s stock valued at $1,389,000 after buying an additional 644 shares during the period. Legacy Advisors LLC lifted its stake in shares of Baxter International by 34.8% during the second quarter. Legacy Advisors LLC now owns 1,483 shares of the medical instruments supplier’s stock valued at $122,000 after buying an additional 383 shares during the period. Finally, Oregon Public Employees Retirement Fund lifted its stake in shares of Baxter International by 0.6% during the second quarter. Oregon Public Employees Retirement Fund now owns 51,927 shares of the medical instruments supplier’s stock valued at $4,253,000 after buying an additional 297 shares during the period. 82.43% of the stock is currently owned by institutional investors.

Several brokerages recently issued reports on BAX. JPMorgan Chase & Co. set a $94.00 price objective on shares of Baxter International and gave the company a “buy” rating in a research note on Tuesday, October 8th. ValuEngine downgraded shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Deutsche Bank initiated coverage on shares of Baxter International in a research note on Monday, October 21st. They set a “buy” rating and a $109.00 price target on the stock. Finally, Piper Jaffray Companies reaffirmed a “buy” rating on shares of Baxter International in a research note on Tuesday, September 10th. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $89.77.

In other Baxter International news, SVP Andrew Frye sold 3,332 shares of the stock in a transaction on Monday, October 14th. The shares were sold at an average price of $88.00, for a total transaction of $293,216.00. Following the transaction, the senior vice president now directly owns 16,391 shares in the company, valued at approximately $1,442,408. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Jacqueline Kunzler sold 5,934 shares of the firm’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $88.12, for a total transaction of $522,904.08. Following the completion of the transaction, the senior vice president now owns 3,089 shares in the company, valued at $272,202.68. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 9,446 shares of company stock valued at $831,917. Company insiders own 0.70% of the company’s stock.

Shares of Baxter International stock traded up $1.42 during trading hours on Wednesday, hitting $82.43. The company’s stock had a trading volume of 1,901,414 shares, compared to its average volume of 2,751,433. The business has a fifty day moving average of $81.52 and a 200 day moving average of $82.75. The company has a market capitalization of $41.85 billion, a PE ratio of 27.03, a P/E/G ratio of 2.11 and a beta of 0.98. Baxter International Inc has a 1-year low of $61.40 and a 1-year high of $89.93. The company has a quick ratio of 2.10, a current ratio of 2.78 and a debt-to-equity ratio of 0.72.

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, December 6th will be issued a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date is Thursday, December 5th. Baxter International’s payout ratio is 28.85%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Recommended Story: How is an ETF different from a mutual fund?

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.